Evaluation of Respiratory Function During Self-induced Cognitive Trance
SPIROTRANSE
1 other identifier
interventional
9
1 country
1
Brief Summary
The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry) The main question: Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2023
CompletedStudy Start
First participant enrolled
May 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2024
CompletedMarch 8, 2024
March 1, 2024
7 months
May 26, 2023
March 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
FEV during a state of self-induced cognitive trance
variation of forced exhaled volume in one second between pre and post phase of cognitive transe
3 month
Secondary Outcomes (6)
PEF during a state of self-induced cognitive trance
3 month
DEM25/50/75 during a state of self-induced cognitive trance
3 month
inspiratory capacity during a state of self-induced cognitive trance
3 month
respiratory rate during a state of self-induced cognitive trance
3 month
SpO2 during a state of self-induced cognitive trance
3 month
- +1 more secondary outcomes
Study Arms (1)
Interventionnal
EXPERIMENTALMeasure DEP, DEM25, DEM 50, DEM 75, FVC, Inspiratory capacity, SpO2, Respiratory rate before, during, or after the state of self-induced cognitive trance Evolution of the feeling of self-efficacy, assessed by questionnaire.
Interventions
Inclusion visit: Performing spirometry. Visit 2 (in the month following the inclusion visit): Induction of a self-induced cognitive trance by the participant; performance of spirometry before, during the trance then 8 minutes after the end of the trance Actimetry during trance
Eligibility Criteria
You may qualify if:
- Person over 18 years old
- Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
- Person affiliated with social security or beneficiary of such a scheme.
- Person having given, in writing, their free and informed consent to participate in the study
You may not qualify if:
- Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection.
- Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study
- Person with a psychiatric, neurological or cardiovascular disease.
- Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis,
- Person with a history of exercise-induced bronchospasm.
- Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics)
- Pregnant woman (declarative).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Metropole Savoie
Chambéry, Savoie, 73011, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pierre IDEE
CH Metropole Savoie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2023
First Posted
November 8, 2023
Study Start
May 26, 2023
Primary Completion
January 1, 2024
Study Completion
March 7, 2024
Last Updated
March 8, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share